Antimetastatic effects of cordycepin mediated by the inhibition of mitochondrial activity and estrogen-related receptor a in human ovarian carcinoma cells

Chia Woei Wang, Wei Hsuan Hsu, Chen Jei Tai

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Cordycepin (3'-deoxyadenosine) is a compound for antitumor, which has been found to exert antiangiogenic, antimetastatic, and antiproliferative effects, as well as inducing apoptosis. However, the association between cancer metastasis and mitochondrial activity in cordycepin-treated ovarian carcinoma cells remains unclear. The 50 and 100 μM of cordycepin inhibits mitochondrial fusion and induces mitochondrial fission, respectively. These suggested that cordycepin showed the down-regulation of mitochondrial function and limitation of energy production. Because of activation of mitochondria and generation of energy are needed in cancer cell migration/invasion. After 24 h treatment, cordycepin suppresses epithelial-mesenchymal transition and migration in ovarian carcinoma cells through inhibiting estrogen-related receptor (ERR)-α. The ERRa is a co-transcription factor for gene expressions associated with mitochondrial fusion. Our results indicate that cordycepin suppresses metastasis and migration of ovarian carcinoma cells via inhibiting mitochondrial activity in non-toxic concentrations, and cordycepin has potential benefits in ovarian cancer therapy.

Original languageEnglish
Pages (from-to)3049-3058
Number of pages10
JournalOncotarget
Volume8
Issue number2
DOIs
Publication statusPublished - 2017

Fingerprint

Estrogen Receptors
Carcinoma
Mitochondrial Dynamics
Neoplasm Metastasis
Epithelial-Mesenchymal Transition
cordycepin
Ovarian Neoplasms
Cell Movement
Neoplasms
Mitochondria
Transcription Factors
Down-Regulation
Apoptosis
Gene Expression

Keywords

  • Antimigration
  • Cordycepin
  • Estrogen-related receptor (ERR)-α
  • Mitochondrial fission
  • Mitochondrial fusion

ASJC Scopus subject areas

  • Oncology

Cite this

Antimetastatic effects of cordycepin mediated by the inhibition of mitochondrial activity and estrogen-related receptor a in human ovarian carcinoma cells. / Wang, Chia Woei; Hsu, Wei Hsuan; Tai, Chen Jei.

In: Oncotarget, Vol. 8, No. 2, 2017, p. 3049-3058.

Research output: Contribution to journalArticle

@article{caf6fcafd1104efcb709c53420f3ddbf,
title = "Antimetastatic effects of cordycepin mediated by the inhibition of mitochondrial activity and estrogen-related receptor a in human ovarian carcinoma cells",
abstract = "Cordycepin (3'-deoxyadenosine) is a compound for antitumor, which has been found to exert antiangiogenic, antimetastatic, and antiproliferative effects, as well as inducing apoptosis. However, the association between cancer metastasis and mitochondrial activity in cordycepin-treated ovarian carcinoma cells remains unclear. The 50 and 100 μM of cordycepin inhibits mitochondrial fusion and induces mitochondrial fission, respectively. These suggested that cordycepin showed the down-regulation of mitochondrial function and limitation of energy production. Because of activation of mitochondria and generation of energy are needed in cancer cell migration/invasion. After 24 h treatment, cordycepin suppresses epithelial-mesenchymal transition and migration in ovarian carcinoma cells through inhibiting estrogen-related receptor (ERR)-α. The ERRa is a co-transcription factor for gene expressions associated with mitochondrial fusion. Our results indicate that cordycepin suppresses metastasis and migration of ovarian carcinoma cells via inhibiting mitochondrial activity in non-toxic concentrations, and cordycepin has potential benefits in ovarian cancer therapy.",
keywords = "Antimigration, Cordycepin, Estrogen-related receptor (ERR)-α, Mitochondrial fission, Mitochondrial fusion",
author = "Wang, {Chia Woei} and Hsu, {Wei Hsuan} and Tai, {Chen Jei}",
year = "2017",
doi = "10.18632/oncotarget.13829",
language = "English",
volume = "8",
pages = "3049--3058",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "2",

}

TY - JOUR

T1 - Antimetastatic effects of cordycepin mediated by the inhibition of mitochondrial activity and estrogen-related receptor a in human ovarian carcinoma cells

AU - Wang, Chia Woei

AU - Hsu, Wei Hsuan

AU - Tai, Chen Jei

PY - 2017

Y1 - 2017

N2 - Cordycepin (3'-deoxyadenosine) is a compound for antitumor, which has been found to exert antiangiogenic, antimetastatic, and antiproliferative effects, as well as inducing apoptosis. However, the association between cancer metastasis and mitochondrial activity in cordycepin-treated ovarian carcinoma cells remains unclear. The 50 and 100 μM of cordycepin inhibits mitochondrial fusion and induces mitochondrial fission, respectively. These suggested that cordycepin showed the down-regulation of mitochondrial function and limitation of energy production. Because of activation of mitochondria and generation of energy are needed in cancer cell migration/invasion. After 24 h treatment, cordycepin suppresses epithelial-mesenchymal transition and migration in ovarian carcinoma cells through inhibiting estrogen-related receptor (ERR)-α. The ERRa is a co-transcription factor for gene expressions associated with mitochondrial fusion. Our results indicate that cordycepin suppresses metastasis and migration of ovarian carcinoma cells via inhibiting mitochondrial activity in non-toxic concentrations, and cordycepin has potential benefits in ovarian cancer therapy.

AB - Cordycepin (3'-deoxyadenosine) is a compound for antitumor, which has been found to exert antiangiogenic, antimetastatic, and antiproliferative effects, as well as inducing apoptosis. However, the association between cancer metastasis and mitochondrial activity in cordycepin-treated ovarian carcinoma cells remains unclear. The 50 and 100 μM of cordycepin inhibits mitochondrial fusion and induces mitochondrial fission, respectively. These suggested that cordycepin showed the down-regulation of mitochondrial function and limitation of energy production. Because of activation of mitochondria and generation of energy are needed in cancer cell migration/invasion. After 24 h treatment, cordycepin suppresses epithelial-mesenchymal transition and migration in ovarian carcinoma cells through inhibiting estrogen-related receptor (ERR)-α. The ERRa is a co-transcription factor for gene expressions associated with mitochondrial fusion. Our results indicate that cordycepin suppresses metastasis and migration of ovarian carcinoma cells via inhibiting mitochondrial activity in non-toxic concentrations, and cordycepin has potential benefits in ovarian cancer therapy.

KW - Antimigration

KW - Cordycepin

KW - Estrogen-related receptor (ERR)-α

KW - Mitochondrial fission

KW - Mitochondrial fusion

UR - http://www.scopus.com/inward/record.url?scp=85009821150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009821150&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.13829

DO - 10.18632/oncotarget.13829

M3 - Article

AN - SCOPUS:85009821150

VL - 8

SP - 3049

EP - 3058

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 2

ER -